Play all audios:
PROPHYLACTIC VERSUS SELECTIVE BLOOD TRANSFUSION FOR SICKLE CELL DISEASE IN PREGNANCY CONTENTS * Abstract * Citation * Links ABSTRACT Sickle cell disease is an inherited disorder of
haemoglobin, the protein in red blood cells that carries oxygen. In this condition, an abnormal haemoglobin S from one parent is combined with another abnormal haemoglobin from the other
parent. Haemoglobin S inherited from both parents (genotype HbSS), described as sickle cell anaemia is the most common form. When oxygen tension is low, haemoglobin S crystallizes and makes
the red blood cells sickle shaped. Sickling reduces red blood cell capacity to manoeuvre through very small blood vessels causing vascular blockage and early destruction of red cells. The
breakdown of red blood cells and massive pooling of damaged red blood cells in the liver and spleen cause anaemia. Acute illnesses include painful crises, pulmonary embolism, acute chest
syndrome and congestive cardiac failure. Therefore, pregnant women with sickle cell disease require careful management. Depending on the institutional policy, blood transfusion can be given
at intervals to a pregnant HbSS woman with relatively few or no symptoms to improve the oxygen carrying capacity of blood by increasing haemoglobin blood concentration and lowering
haemoglobin S levels; or only when indicated by the development of medical or pregnancy complications. Giving blood at frequent intervals carries the risks of blood-borne infections and
excessive levels of iron. This review set out to determine whether giving blood at intervals before serious complications occur compared with giving blood only when medically indicated makes
a difference to the health of the mother and her baby. The review authors included two controlled trials that randomised 98 women with sickle cell anaemia (haemoglobin SS) before 28 weeks
of gestation to one of the two blood transfusion policies. The two trials were of low quality. One trial (72 women) indicated no difference in severe ill health and death of the mother or
newborn. There was no difference in the risk of delayed blood transfusion reaction. The two trials suggested giving blood at frequent intervals marginally reduced the risk of pain crisis,
with a large degree of uncertainty about the size of the effect, compared with giving blood only when medically indicated. Blood transfusion was delivered at a ratio of four or five to one
for prophylactic versus selective blood transfusion, respectively. Overall, available evidence on this subject is insufficient to advocate for a change in clinical practice and policy.
CITATION Okusanya, B.O.; Oladapo, O.T. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database of Systematic Reviews (2013) Issue 12, Art.
No.: CD010378. [DOI: 10.1002/14651858.CD010378.pub2] LINKS Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy UPDATES TO THIS PAGE Published 1 January 2013
Contents